Objectives: The present study was carried out to determine whether inhalation of hydrogen (H 2 ) gas protects myocardium against ischemia-reperfusion (I/R) injury in swine.
Introduction
The prognosis of acute myocardial ischemia has been improved dramatically with the development of highly successful approaches to restore blood flow by primary percutaneous coronary intervention (PCI) to the ischemic tissue. However, coronary reperfusion also leads to myocardial reperfusion injury by generation of reactive oxygen species (ROS) from mitochondria. The accelerated generation of ROS by reperfusion of the ischemic myocardium is a potential mediator of reperfusion injury [1] [2] [3] . It was demonstrated that hydrogen (H 2 ) is a novel antioxidant agent which specifically quenches exclusively detrimental ROS, such as hydroxy radical (
• OH) and peroxynitrite (ONOO -), and that inhalation of H 2 gas confers protection in focal brain ischemia reperfusion (I/R) injury in rats [4] . This observation was echoed by others in different organs such as intestine [5] , liver [6] , kidney [7] , and heart [8] in small animal models.
Myocardial stunning is defined as prolonged, but reversible post-ischemic contractile dysfunction following a brief ischemic episode lasting less than 20 min that does not result in necrosis or multiple completely reversible episodes of ischemia [9] [10] [11] .
It occurs in unstable angina, exercise-induced ischemia, PCI, and open heart surgery [12] . It has been shown that • OH is the key mediator of stunning. The derivatives are present in stunned tissue and can be detected in the coronary effluent [13] . The fact that deferoxamine, which chelates Fe and thereby prevents the Fe-catalyzed reaction that generates
• OH, prevents much of the stunning effect is further evidence that
• OH is the mediator of stunning [14, 15] . In addition, any nitric oxide (NO) released during reperfusion can react with superoxide to form ONOO -, another strong free radical that can cause stunning. It is not known whether H 2 provides protection against myocardial stunning.
The present study was carried out to clarify whether inhalation of H 2 gas during ischemia and reperfusion has cardioprotective effects against myocardial stunning or myocardial infarction in swine.
Materials and Methods
All experimental procedures and protocols described in this study were approved by the Institutional Animal Care and Use Committee. Date of issue and registration number is November 9 2007 and No. 711090631.
General Preparation
Forty-nine swine of either sex weighing 20-30 kg were sedated with 20 mg/kg intramuscular ketamine hydrochloride. Surgical preparation was performed as described previously [16] . Swine were anesthetized with 100 mg/kg intravenous alpha-chloralose and 10 µ/kg fentanyl, followed by continuous infusion of 10 mg/kg/h alpha-chloralose and 5 µg/kg/h fentanyl throughout the study period. Through a midline cervical incision, the trachea was intubated for connection to a Harvard respirator pump (Harvard Apparatus Co., South Natrick, MA, USA). 
Experimental Protocol
Study 1: myocardial stunning model Figure 1 shows the experimental time course. Baseline systemic and coronary hemodynamics and %SS were recorded 30 min after the instrumentation was completed.
Nineteen swine were randomly assigned to group A or B. Group A (n=9) received 100 % oxygen during and after ischemia. Group B (n=10) received 2% hydrogen plus 98 % oxygen during and after ischemia. All swine were subjected to 12-min ischemia with complete occlusion of the extracorporeal circuit followed by a 90-min reperfusion. continuous VF or VT after a defibrillation were excluded from the study.
Determination of Infarct Size (IS)
Determination of IS was performed as described previously [17] . After final hemodynamics and contractile function data collection, the LAD was occluded. The ascending aorta was cross-clamped, and 40 ml of Evans Blue solution was injected into the left atrial appendage to stain normally perfused myocardium. Immediately thereafter, 20 mmol of potassium chloride solution was injected into the same site to induce cardiac arrest. The heart was resected, and the LV was cut into six 6-8 mm slices starting 5 mm from the apex and perpendicular to the long axis. The slices were placed in 1% triphenyl tetrazolium chloride solution for 15 min to determine myocardial IS of area at risk (AAR). Photographs of each LV section were processed to divide each transection into three color areas of blue (unaffected myocardium), red (noninfarcted area of AAR), or gray (infarcted area), before performing computerized planimetry (ImageJ 1.34 software, NIH public domain, USA). The respective areas for each color from all six sections were normalized to the total sum of areas. The size of the myocardial AAR, as related to total area, and the myocardial IS in relation to AAR were calculated as follows:
AR [%] = ∑(a gray1+ a red1 ․․․a gray6+ a red6)/ ∑(a gray1+ a red1+ a blue1 ․․․a gray6+ a red6+ a blue6)
Statistical Analysis
All data were expressed as mean ± SD. One-way analysis of variance (ANOVA) for non-repeated measures followed by the Bonferroni's post hoc test was used to test for differences in baseline hemodynamics and %SS. Data within groups were analyzed with one-way ANOVA for repeated measures, and data between groups were analyzed with two-way repeated measures ANOVA followed by the Bonferroni's post hoc test. P values <0.05 were considered statistically significant.
Results

Study 1: myocardial stunning model
Three in group A and two in group B had continuous VF or VT after reperfusion, and they were excluded from further study. Thus, results were reported for six animals in group A and eight in group B. The incidence of VF or VT and the total amount of lidocaine used were not significantly different between the groups (data not shown). There were no significant differences in weight or sex between the groups.
Arterial blood gas values and blood glucose were maintained within physiological range in all swine throughout the study period (data not shown). Table 1 shows the systemic and coronary hemodynamics from baseline throughout the time course of the study 1.
There were no significant differences between the groups at any measured point in heart rate (HR), mean arterial pressure (MAP), LV end-diastolic pressure (LVEDP), or LVdp/dt max. CBF increased significantly at 5 min after reperfusion and returned to baseline thereafter, and there were no significant differences at any measured point between the groups. Baseline values of %SS were 20 ± 5 in group A and 20 ± 4 in group B, respectively, and there was no significant difference between the groups. Figure 2 shows the percent changes of %SS from baseline throughout the time course of the study. All swine showed negative %SS values at 10 min after ischemia, which indicates bulging. The percent changes of %SS at 30-, 60-, and 90-min reperfusion in group B (72 ± 14%, 75 ± 9% and 79 ± 14% of baseline, respectively) were significantly higher than those in group A (47 ± 16%, 47 ± 17% and 48 ± 15% of baseline, respectively).
Study 2: myocardial infarction model
Seven animals were excluded from the analysis. Two swine in group C, two swine in group D and one swine in group E had VF or VT after reperfusion. One swine in group D and one swine in group E were excluded from the analysis because of failed myocardial staining. Thus, results are reported for seven animals in group D and eight in groups C and E. Table 2 shows the systemic and coronary hemodynamics throughout the time course in study 2. There were no significant differences between the groups at any measured point in HR, MAP, LVEDP, LVdp/dt max, CBF or %SS. Figure 3 shows myocardial IS in relation to AAR. The AAR for myocardial infarction as related to total LV area was 26 ± 4 %, 27 ± 5 %, and 28 ± 3 % in groups C, D, and E, respectively. There were no significant differences among the groups. Myocardial IS in group E (32 ± 10 %) was significantly lower than that in group C (46 ± 6 %).
During the first 10 min of reperfusion, electrical cardioversion was necessary in ten animals because of sustained VT, with equal distribution over the groups.
Sakai
Discussion
The present results show that inhalation of 2% H 2 gas during I/R improves the recovery from myocardial stunning, and that inhalation of 4% but not 2% H 2 gas reduces myocardial IS in swine.
The accelerated generation of ROS by reperfusion of ischemic myocardium is a potential mediator of reperfusion injury. Unfortunately, however, therapy to reduce ROS during early reperfusion failed to relieve this pathological cascade of oxidative damage after reperfusion injury. There are a number of possible reasons for this result. (ml/min) Group B 29 ± 7 0* 47± 8* 27 ± 7 29 ± 6 31± 8 %SS Group A 20 ± 5 -1± 2* 9 ± 6* 10 ± 6* 10 ± 7* 10 ± 6* (%) Group B 20 ± 4 -1± 2* 11 ± 3* 15 ± 4*✝ 15± 4*✝ 16± 3*✝ Values are Mean ± SD. Ischemia 10 = 10 min after ischemia; R 5, R 30, R 60, and R 90 = 5, 30, 60, and 90 min after reperfusion; HR = heart rate; MAP = mean arterial pressure; LVEDP = left ventricular end-diastolic pressure; LVdp/dt max = maximal rate of increase of left ventricular pressure ; CBF = coronary blood flow; %SS = % segment shortening. *: p < 0.05 vs baseline. ✝: p < 0.05 vs group A .
Group E 2314 ± 441 1854 ± 436* 1630± 486* 1775± 289* 1758± 201* 1940± 308* CBF Group C 30 ± 9 0* 36 ± 8 37± 9 36 ± 6 34± 8
(ml/min) Group D 31 ± 6 0* 32 ± 13 39 ± 9 36 ± 6 33± 13
Group E 34 ± 6 0* 33 ± 9 33 ± 11 32 ±11 31 ± 12 %SS Group C 24 ± 4 -1± 2* -3 ± 5* -2 ± 4* -2 ± 3* -2 ± 3* (%) Group D 25 ± 8 -3± 2* -6 ± 6* -1 ± 3* -2 ± 2* -4± 2* Group E 21 ± 4 0 ± 2* -1 ± 6* 0 ± 4* -1 ± 3* -1 ± 3*
Values are Mean ± SD. Ischemia 30 = 30 min after ischemia; R 5, R 30, R 60, and R 120 = 5, 30, 60, and 120 min after reperfusion; HR = heart rate; MAP = mean arterial pressure; LVEDP = left ventricular end-diastolic pressure; LVdp/dt max = maximal rate of increase of left ventricular pressure ; CBF = coronary blood flow; %SS = % segment shortening. *: p < 0.05 vs baseline.
